Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

BACKGROUND: Malignancies are molecularly complex and become more resistant with each line of therapy. We hypothesized that offering matched, individualized combination therapies to patients with treatment-naïve, advanced cancers would be feasible and efficacious. Patients with newly diagnosed unrese...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicklick, Jason K., Kato, Shumei, Okamura, Ryosuke, Patel, Hitendra, Nikanjam, Mina, Fanta, Paul T., Hahn, Michael E., De, Pradip, Williams, Casey, Guido, Jessica, Solomon, Benjamin M., McKay, Rana R., Krie, Amy, Boles, Sarah G., Ross, Jeffrey S., Lee, J. Jack, Leyland-Jones, Brian, Lippman, Scott M., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491393/
https://www.ncbi.nlm.nih.gov/pubmed/34607609
http://dx.doi.org/10.1186/s13073-021-00969-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491393/
https://www.ncbi.nlm.nih.gov/pubmed/34607609
http://dx.doi.org/10.1186/s13073-021-00969-w

Ejemplares similares